A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis
- 20 October 2006
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 78 (5) , 465-469
- https://doi.org/10.1136/jnnp.2006.098327
Abstract
Background: The issue of when to start treatment in Parkinson’s disease (PD) remains controversial. Some favour treatment at diagnosis while others opt for a “wait and watch” policy. The effect of the latter policy on the self reported health status of people with PD is unknown. Aims: To record self reported health status through longitudinal use of a validated PD specific questionnaire (PDQ-39) in untreated PD patients in multiple centres in the UK. To compare patients who were left untreated with those who were offered treatment during follow-up. Methods: A multicentre, prospective, “real life” observational audit based study addressing patient reported outcomes in relation to self reported health status and other sociodemographic details. Results: 198 untreated PD were assessed over a mean period of 18 months. During two follow-up assessments, the self reported health status scores in all eight domains of the PDQ-39 and the overall PDQ-39 summary index worsened significantly (pConclusions: This study addresses for the first time self reported health status, an indicator of health related quality of life, in untreated PD. The findings may strengthen the call for re-evaluation of the policy to delay treatment in newly diagnosed patients with PD.Keywords
This publication has 18 references indexed in Scilit:
- Pramipexole vs Levodopa as Initial Treatment for Parkinson DiseaseArchives of Neurology, 2004
- Slowing Parkinson’s disease progression: Recent dopamine agonist trialsNeurology, 2004
- The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendationsMovement Disorders, 2003
- Development and testing of the Parkinson's disease quality of life scaleMovement Disorders, 2003
- Measuring motor complications in clinical trials for early Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Dopamine agonist monotherapy in Parkinson's diseaseThe Lancet, 2002
- Factors impacting on quality of life in Parkinson's disease: Results from an international surveyMovement Disorders, 2002
- Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaireAge and Ageing, 2001
- An algorithm (decision tree) for the management of Parkinson’s disease (2001):Neurology, 2001
- The EQ-5D---a generic quality of life measure---is a useful instrument to measure quality of life in patients with Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2000